Macter expands Cobolmin range with sublingual option

MG News | December 22, 2025 at 03:55 PM GMT+05:00

0:00

December 22, 2025 (MLN): Macter International Limited (PSX: MACTER) introduced Cobolmin SL, a sublingual formulation of Mecobalamin.

The company stated that Cobolmin SL offers rapid absorption and enhanced convenience for patients through sublingual administration, the company’s filing on PSX revealed today.

The product expands the existing Cobolmin range, which includes tablets and injections, and underscores Macter International’s focus on innovation in healthcare.

At the time of writing, MACTER shares were trading at Rs 337.59, up 2.51 points, or 0.75%.

Copyright Mettis Link News

Related News

PSX Closing Bell: The Tide Turns Red

Mari D&PL well hits gas flow

SBP approves BAFL capital clause changes

Name	Price/Vol	%Chg/NChg
KSE100	152,740.38 147.44M	-1.01% -1551.88
ALLSHR	91,858.47 324.25M	-0.86% -800.10
KSE30	46,223.61 86.89M	-1.45% -681.25
KMI30	219,130.92 66.08M	-1.15% -2553.50
KMIALLSHR	59,625.28 139.61M	-0.93% -562.17
BKTi	42,104.46 39.09M	-2.02% -866.56
OGTi	32,077.87 10.13M	-1.27% -414.19

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	70,530.00	71,480.00 69,755.00	170.00 0.24%
BRENT CRUDE	110.19	111.22 105.05	1.54 1.42%
RICHARDS BAY COAL MONTHLY	99.40	0.00 0.00	-11.80 -10.61%
ROTTERDAM COAL MONTHLY	123.30	0.00 0.00	0.00 0.00%
USD RBD PALM OLEIN	1,083.50	1,083.50 1,083.50	0.00 0.00%
CRUDE OIL - WTI	95.88	96.45 92.47	0.33 0.35%
SUGAR #11 WORLD	15.40	15.47 15.27	0.03 0.20%